Skip to main content

OSA clinical trials at UC Health

1 research study open to eligible people

Showing trials for
  • Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea

    open to eligible people ages 18-65

    Obstructive sleep apnea (OSA) is common and associated with many adverse health consequences, but many patients are unable to tolerate standard therapies such as continuous positive airway pressure (CPAP) and thus remain untreated. Single-drug therapies have shown promising results in treating sleep apnea, but on average patients have only experienced partial relief. Multi-drug therapy may offer a more effective treatment approach. The goal of this study is to test the effect of combination therapy with three FDA-approved drugs (Diamox [acetazolamide], Lunesta [eszopiclone] +/- Effexor [venlafaxine]) on OSA severity and physiology.

    at UCSD

Last updated: